The efficacy of Eplerenon drug in patient with Acute CSCR (Central SerousChorioretinopathy)
Phase 3
Recruiting
- Conditions
- Central serous chorioretinopathyH35.71Central Serous Chorioretinopathy.
- Registration Number
- IRCT20180825040860N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Acute onset of disease (less than 3 months)
without history of previous treatments including treatment with drugs, PDT, Photocuagulation LASER
absence of any pathology and impaired vision in other eye
absence of ophthalmic eye pathology such as Glaucoma, Retinal disease and uveitis
not taking corticostroids agents
normal kidney lab tests for treatment group
having consent to participating in study
Exclusion Criteria
does not having Consent to participating in study
Younger than 18 years old
suffering from any ocular or kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method